Cargando…
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas
Recurrence rates after breast-conserving therapy may depend on genomic characteristics of cancer-adjacent, benign-appearing tissue. Studies have not evaluated recurrence in association with multiple genomic characteristics of cancer-adjacent breast tissue. To estimate the prevalence of DNA defects a...
Autores principales: | Troester, Melissa A, Hoadley, Katherine A, D’Arcy, Monica, Cherniack, Andrew D, Stewart, Chip, Koboldt, Daniel C, Robertson, A Gordon, Mahurkar, Swapna, Shen, Hui, Wilkerson, Matthew D, Sandhu, Rupninder, Johnson, Nicole B, Allison, Kimberly H, Beck, Andrew H, Yau, Christina, Bowen, Jay, Sheth, Margi, Hwang, E Shelley, Perou, Charles M, Laird, Peter W, Ding, Li, Benz, Christopher C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515343/ https://www.ncbi.nlm.nih.gov/pubmed/28721375 http://dx.doi.org/10.1038/npjbcancer.2016.7 |
Ejemplares similares
-
Prediction of Toxicant-Specific Gene Expression Signatures after Chemotherapeutic Treatment of Breast Cell Lines
por: Troester, Melissa A., et al.
Publicado: (2004) -
Integrated RNA and DNA sequencing improves mutation detection in low purity tumors
por: Wilkerson, Matthew D., et al.
Publicado: (2014) -
Gene expression patterns associated with p53 status in breast cancer
por: Troester, Melissa A, et al.
Publicado: (2006) -
Impact of stromal microenvironment on metabolic phenotypes in breast cancer: evidence for stroma-influenced Warburg effect
por: Brauer, Heather Ann, et al.
Publicado: (2012) -
TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study
por: Hurson, Amber N., et al.
Publicado: (2022)